Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
PHP Toggle Menu

Category: 2024

Transgene, Nec, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Transgene Nec and BostonGene expand collaboration

Published 5 March 2024
Categorized as 2024, categorie-orpheline, dates, dates, Myvac, Press release, TG4050

Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer

financial calendar 2024

Published 22 January 2024
Categorized as 2024, categorie-orpheline, dates, dates, Press release

Transgene Announces Financial Calendar for 2024

financial calendar 2024

Published 22 January 2024
Categorized as 2024, categorie-orpheline, dates, dates, Press release

Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050

Transgene and NEC extend their collaboration

Published 8 January 2024
Categorized as 2024, dates, Myvac, Press release, TG4050

Posts pagination

Newer posts Page 1 … Page 4
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
Menu